Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Roux-en-Y gastric bypass alters microbial circadian rhythms with links to metabolic improvement.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: June 24, 2026
Clostridioides difficile Infection Among Hospitalized Patients With Cancer.
Journal: JAMA network open
Published: March 25, 2026
Continuing Medical Education Questions: January 2026.
Journal: The American journal of gastroenterology
Published: February 04, 2026
Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial.
Journal: Inflammatory bowel diseases
Published: January 23, 2026
Discordant Clostridioides difficile testing as a predictor of inflammatory bowel disease therapy escalation.
Journal: Inflammatory bowel diseases
Published: October 06, 2025
Ustekinumab versus vedolizumab and ustekinumab versus tumor necrosis factor alpha agent infectious adverse effects in patients with ulcerative colitis, a real-world data study.
Journal: Expert opinion on pharmacotherapy
Published: September 18, 2025
Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Journal: Circulation. Heart failure
Published: May 16, 2025
Metagenomic source tracking after microbiota transplant therapy.
Journal: Gut microbes
Published: April 14, 2025
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights.
Journal: Gut microbes
Published: March 10, 2025
Microbiota Transplant Therapy Is Safe and Feasible in Pulmonary Arterial Hypertension.
Journal: JACC. Basic to translational science
Published: March 05, 2025
Last Updated: 09/26/2026